TrialBlood2021
Acalabrutinib in treatment-naive chronic lymphocytic leukemia.
John C Byrd et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled ittrialcites it
TrialBlood2021
John C Byrd et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.